Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,735,010 papers from all fields of science
Search
Sign In
Create Free Account
ceritinib 150 MG Oral Capsule [Zykadia]
Known as:
Zykadia 150 MG Oral Capsule
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Gelatin
Indigo Carmine
Magnesium stearate
Oral Capsule
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
L. Claxton
,
Joanne O’Connor
,
N. Woolacott
,
Kath Wright
,
R. Hodgson
PharmacoEconomics (Auckland)
2018
Corpus ID: 52936643
The National Institute for Health and Care Excellence (NICE) invited the company that manufactures ceritinib (Zykadia®, Novartis…
Expand
2017
2017
Ceritinib (Zykadia®) as first-line therapy for patients with advanced ALK-positive non-small cell lung cancer
L. McGahan
2017
Corpus ID: 80361634
Ceritinib, a highly selective second-generation anaplastic lymphoma kinase (ALK) inhibitor, suppresses the phosphorylation of ALK…
Expand
Review
2015
Review
2015
Review of the use of ceritinib, a newly approved anaplastic lymphoma kinase (ALK) inhibitor, in crizotinib-resistant anaplastic lymphoma kinase-rearranged non-small cell lung cancer
S. Thomas
,
A. Gyapong
,
N. Greenfield
2015
Corpus ID: 53883757
The purpose of this poster is to provide a summary of data on ceritinib, that shows exceptional potency against ALK mutations…
Expand